Recombinant human alpha-2a interferon promotes an atypical process of mast cell secretion with ultrastructural

Enrico Crivellato1, Luigi Candussio, Franco Mallardi

  • 1Department of Medical and Morphological Research, Anatomy Section, University of Udine Medical School, Udine, Italy.

Journal of Anatomy
|December 20, 2002
PubMed

Insights

Recombinant human interferon-alpha 2a (rhIFN-alpha 2a) triggers mast cell (MC) degranulation in rats. Ultrastructural analysis revealed changes like granule dilation and piecemeal degranulation, with minimal histamine release.

Area of Science:

  • Immunology
  • Cell Biology
  • Histamine Research

Background:

  • Mast cells (MC) are key immune cells involved in allergic reactions and inflammation.
  • Interferons, like interferon-alpha (IFN-alpha), modulate immune responses.
  • Understanding MC activation pathways is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the ultrastructural effects of recombinant human interferon-alpha 2a (rhIFN-alpha 2a) on rat peritoneal mast cells.
  • To quantify histamine release from mast cells stimulated with rhIFN-alpha 2a.

Main Methods:

  • Purified rat peritoneal mast cells were isolated and stimulated in vitro with rhIFN-alpha 2a.
  • Ultrastructural changes were examined using electron microscopy.
  • Histamine release was quantitatively measured.

Main Results:

  • Observed ultrastructural changes included granule dilation, formation of cytoplasmic cavities, and piecemeal degranulation.
  • Focal exocytosis and small secretory channels were also noted.
  • A slight, though not statistically significant, increase in histamine release was detected in rhIFN-alpha 2a-treated mast cells.

Conclusions:

  • rhIFN-alpha 2a induces a distinct pattern of degranulation in rat peritoneal mast cells.
  • Piecemeal degranulation is suggested by observed ultrastructural features in a subset of stimulated mast cells.